| Announce Date | 10/28/2025 |
| EPS Normalized Actual | $0.3818 (Miss by $-0.6782) |
| EPS GAAP Actual | $0.3818 (Miss by $-0.6782) |
| Revenue Actual | $214.638B |
| Revenue Surprise | Beat by $214638M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 147.08766 | 0.76 | 138.01098 | 156.78823 | 1 |
| Dec 2029 | 158.33322 | 0.7 | 142.27492 | 164.21472 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 33.7 | 33.7 | 214.638B | 2.95% | 214638M |
| FQ2 2025 (Jun 2025) | 15.6 | 15.6 | 211.364B | 5.97% | 211364M |
| FQ1 2025 (Mar 2025) | 37 | 37 | 195.82B | 9% | 195820M |
| FQ4 2024 (Dec 2024) | 0.49 | 0.49 | 208.311B | 8.87% | 208311M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 196.771B | 4.41% | 196771M |
| FQ2 2024 (Jun 2024) | 3.52 | 3.52 | 198.745B | 0.26% | 198745M |
| FQ1 2024 (Mar 2024) | 1.68 | 1.68 | 178.204B | -1.01% | 178204M |
| FQ4 2023 (Dec 2023) | 0.91 | 0.91 | 189.825B | 1.77% | 189825M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2029 (Sep 2029) | 33.5884 | -- | 32.94087 | 34.67211 | 1 |
| FQ2 2029 (Jun 2029) | 29.45658 | -- | 28.8887 | 30.40698 | 1 |
| FQ1 2029 (Mar 2029) | 23.59125 | -- | 23.13645 | 24.35241 | 1 |
| FQ3 2028 (Sep 2028) | 30.74921 | -- | 30.15641 | 31.74132 | 1 |
| FQ2 2028 (Jun 2028) | 26.79234 | -- | 26.27582 | 27.65678 | 1 |
| FQ1 2028 (Jan 2028) | 41.25379 | -- | 40.63943 | 42.24356 | 1 |
| FQ4 2027 (Oct 2027) | 37.6859 | -- | 37.12467 | 38.59007 | 1 |
| FQ3 2027 (Jul 2027) | 38.24338 | -- | 37.67385 | 39.16093 | 1 |
| FQ2 2027 (Apr 2027) | 30.7731 | -- | 30.31482 | 31.51142 | 1 |
| FQ1 2027 (Jan 2027) | 36.9458 | -- | 36.3956 | 37.83221 | 1 |
| FQ4 2026 (Oct 2026) | 28.61407 | -17.77 | 28.18794 | 29.30059 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2029 (Sep 2029) | 419.45B | -- | 413.23B | 429.86B | 1 |
| FQ2 2029 (Jun 2029) | 401.95B | -- | 395.99B | 411.92B | 1 |
| FQ1 2029 (Mar 2029) | 385.17B | -- | 379.46B | 394.73B | 1 |
| FQ3 2028 (Sep 2028) | 353.69B | -- | 348.45B | 362.47B | 1 |
| FQ2 2028 (Jun 2028) | 338.93B | -- | 333.91B | 347.35B | 1 |
| FQ1 2028 (Jan 2028) | 278.5B | -- | 275.31B | 283.64B | 1 |
| FQ4 2027 (Oct 2027) | 270.56B | -- | 267.46B | 275.55B | 1 |
| FQ3 2027 (Jul 2027) | 262.84B | -- | 259.83B | 267.69B | 1 |
| FQ2 2027 (Apr 2027) | 255.34B | -- | 252.42B | 260.05B | 1 |
| FQ1 2027 (Jan 2027) | 266.54B | -- | 263.48B | 271.45B | 1 |
| FQ4 2026 (Oct 2026) | 258.22B | 16.88 | 255.27B | 262.99B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 33.7 | 33.7 | 100% | |
| FQ2 2025 (Jun 2025) | 15.6 | 15.6 | 100% | |
| FQ1 2025 (Mar 2025) | 37 | 37 | 100% | |
| FQ4 2024 (Dec 2024) | 0.49 | 0.49 | 100% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 3.52 | 3.52 | 100% | |
| FQ1 2024 (Mar 2024) | 1.68 | 1.68 | 100% | |
| FQ4 2023 (Dec 2023) | 0.91 | 0.91 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0B | $214.64B | $214638M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $211.36B | $211364M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $195.82B | $195820M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $208.31B | $208311M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $196.77B | $196771M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $198.75B | $198745M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $178.2B | $178204M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $189.83B | $189825M | 100% |